High-risk breast lesions at imaging-guided needle biopsy: Usefulness of MRI for treatment decision

American Journal of Roentgenology

Volumn 199, Issue 2, 2012, Pages

  Londero, Viviana ^a   Zuiani, Chiara ^a   Linda, Anna ^a   Girometti, Rossano ^a   Bazzocchi, Massimo ^a   Sardanelli, Francesco ^b  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Breast cancer; Contrast enhanced MRI; Core needle biopsy; High risk breast lesions; Vacuum assisted biopsy

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST BIOPSY; BREAST LESION; BREAST PAPILLOMA; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGING GUIDED NEEDLE BIOPSY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LOBULAR NEOPLASIA; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS BIOPSY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIAL SCLEROSING LESION; RETROSPECTIVE STUDY; VACUUM ASSISTED BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DECISION MAKING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL; ULTRASONOGRAPHY, MAMMARY;

EID: 84864778650     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7869     Document Type: Article

References (46)

1. Hayes BD, O'Doherty A, Quinn CM. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merriot Breast Screening Unit experience. J Clin Pathol 2009; 62:1136-1140
2. Houssami N, Ciatto S, Bilous M, Vezzosi V, Bianchi S. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br J Cancer 2007; 96:1253-1257 (Pubitemid 46625079)
3. El-Sayed ME, Rakha EA, Reed J, Lee AHS, Evans AJ, Ellis IO. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 2008; 53:650-657 (Pubitemid 352768713)
4. Lee AHS, Denley HE, Pinder SE, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 2003; 42:331-336 (Pubitemid 36459810)
5. Dillon MF, McDermott EW, Hill AD, O'Doherty A, O'Higgins N, Quinn CM. Predictive value of breast lesions of "uncertain malignant potential"determined by needle core biopsy. Ann Surg Oncol 2007; 14:704-711 (Pubitemid 46178336)
6. Lieske B, Ravichandran D, Alvi A, Lawrence DAS, Wright DJ. Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur J Surg Oncol 2008; 34:1293-1298
7. Londero V, Zuiani C, Linda A, Battigelli L, Brondani G, Bazzocchi M. Borderline breast lesions: comparison of malignancy underestimation rates with 14-gauge core needle biopsy versus 11-gauge vacuum-assisted device. Eur Radiol 2011; 21:1200-1206
8. Bianchi S, Caini S, Renne G, et al. Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. Breast 2011; 20:264-270
9. European Commission Working Group on Breast Screening Pathology. Quality assurance guidelines for pathology. In: Perry N, Broeders M, de Wolf C, et al., eds. European guidelines for quality assurance in breast cancer screening and diagnosis. Luxemburg: Office for Official Publications of the European Communities, 2006:219-312
10. Non-Operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening: publication no. 50. Sheffield, UK: NHS Cancer Screening Programmes, 2001
11. Pinder SE, Reis-Filho JS. Non-operative breast pathology. J Clin Pathol 2007; 60:1297-1299 (Pubitemid 350247243)
12. Provenzano E, Pinder SE. Pre-operative diagnosis of breast cancer in screening: problems and pitfalls. Pathology 2009; 41:3-17
13. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol 2002; 26:1095-1110 (Pubitemid 34969180)
14. Johnson NB, Collins LC. Update on percutaneous needle biopsy of nonmalignant breast lesions. Adv Anat Pathol 2009; 16:183-195
15. Hayes BD, Quinn CM. Pathology of B3 lesions of the breast. Diagn Histopathol 2009; 15:459-469
16. Georgian-Smith D, Lawton TJ. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective. Radiol Clin North Am 2010; 48:999-1012
17. Lawton TJ, Georgian-Smith D. Excision of high-risk breast lesions on needle biopsy: is there a standard of core? AJR 2009; 192:W268
18. Berg WA. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am 2004; 42:935-946 (Pubitemid 39165073)
19. Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000; 216:831-837 (Pubitemid 30660861)
20. Kuhl CK. The current status of breast MR imaging. Part 1. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007; 244:356-378
21. Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 2007; 45:863-880 (Pubitemid 47410063)
22. Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I, Parizel P. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 2006; 32:901-910 (Pubitemid 44636925)
23. Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 2009; 198:262-269
24. Schouten van der Velden AP, Boetes C, Bult P, Wobbes T. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006; 192:172-178 (Pubitemid 44066305)
25. Linda A, Zuiani C, Bazzocchi M, Furlan A, Londero V. Borderline breast lesions diagnosed at core needle biopsy: can magnetic resonance mammography rule out associated malignancy? Preliminary results based on 79 surgically excised lesions. Breast 2008; 17:125-131
26. Pediconi F, Padula S, Dominelli V, et al. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Radiology 2010; 257:653-661
27. Linda A, Zuiani C, Furlan A, et al. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR 2012; 198:272-280
28. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211:101-110 (Pubitemid 29161739)
29. Ikeda DM, Hylton NM, Kuhl CK, et al. BI-RADS: magnetic resonance imaging, 1st ed. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS - breast imaging atlas. Reston, VA: American College of Radiology, 2003
30. Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 2009; 133:15-25
31. Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 2009; 133:1515-1538
32. Jansen SA. Ductal carcinoma in situ: detection, diagnosis, and characterization with magnetic resonance imaging. Semin Ultrasound CT MRI 2011; 32:306-318
33. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007; 370:485-492 (Pubitemid 47214635)
34. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007; 244:672-691 (Pubitemid 47292079)
35. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 2008; 18:1307-1318
36. Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 2010; 46:1296-1316
37. Bassett LW, Dhaliwal SG, Eradat J, et al. National trends and practices in breast MRI. AJR 2008; 191:332-339
38. Strigel RM, Eby PR, DeMartini WB, et al. Frequency, upgrade rates, and characteristics of highrisk lesions initially identified with breast MRI. AJR 2010; 195:792-798
39. Crystal P, Sadaf A, Bukhanov K, McCready D, O'Malley F, Helbich TH. High risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted? Eur Radiol 2011; 21:582-589
40. Sardanelli F, Bacigalupo L, Carbonaro L, et al. What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard? Radiol Med (Torino) 2008; 113:439-451
41. Liberman L, Holland AE, Marjan D, et al. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR 2007; 188:684-690
42. Kurz KD, Roy S, Mödder U, Skaane P, Saleh A. Typical atypical findings on dynamic MRI of the breast. Eur J Radiol 2010; 76:195-210
43. Bhattarai N, Kanemaki Y, Kurihara Y, Nakajima Y, Fukuda M, Maeda I. Intraductal papilloma: features on MR ductography using a microscopic coil. AJR 2006; 186:44-47 (Pubitemid 46100358)
44. Rovno HD, Siegelman ES, Reynolds C, Orel SG, Schnall MD. Solitary intraductal papilloma: findings at MR imaging and MR galactography. AJR 1999; 172:151-155 (Pubitemid 29028448)
45. Daniel BL, Gardner RW, Birdwell RL, et al. Magnetic resonance imaging of intraductal papilloma of the breast. Magn Reson Imaging 2003; 21:887-892 (Pubitemid 37377482)
46. National Cancer Institute. Breast cancer. National Cancer Institute Web site. www.cancer.gov/cancertopics/types/breast. Accessed August 21, 2011